ANA News
2021-06-23 – NIH Director Francis Collins, MD, PhD, reported on June 10 that the first infrastructure awards supporting the RECOVER (REsearching COVID to Enhance Recover) Initiative, previously known as the Post-Acute Sequelae of SARS-CoV-2 infection (PASC) Initiative, have been allocated. These and additional…
2021-06-18 – EVENT TITLE: Dialogue: Current Perspectives on Aducanumab DATE/TIME: June 21, 2021 (10 am - 2pm CT) AUDIENCE: Open to All OBJECTIVE: On June 7, 2021, the FDA made a decision to approve Biogen’s BLA submission of aducanumab for the treatment of Alzheimer’s disease. The Alzheimer’s Association has…
2021-06-18 – Check out these articles authored by ANA members recently accepted by and/or published in the Annals of Neurology: Characterization of Extracranial Giant Cell Arteritis with Intracranial Involvement and its Rapidly Progressive SubtypeReply to: Neurofilament Light Chain in Patients with COVID-19 and…
2021-06-17 – The American Brain Coalition, American College of Neuropsychopharmocology, Allen Institute, International Neuroethics Society, The Kavli Foundation, Simons Foundation and Society for Neuroscience, in cooperation with the Congressional Neuroscience Caucus,are hosting a Virtual Briefing celebrating…
2021-06-16 – With the widespread use of vaccines to protect against infection by the SARS-Cov2 virus, there is intense interest in possible low-frequency but clinically significant complications. Annals of Neurology announces two new research articles, one from India and one from England, both reporting…
2021-06-15 – The House voted 216-206 on a “deeming” resolution (H. Res. 467) on June 14, establishing a $1.506 trillion top-line spending limit for FY 2022 funding bills, also known as the 302(a) allocation. The House resolution does not specify levels for defense and nondefense discretionary funding within the…
2021-06-14 – The NFL-NFLPA Pain Management Committee (PMC) has launched a formal Request for Proposal (RFP) process aimed at supplementing the PMC's knowledge about pain management and the potential effects of pain and cannabinoids on athletic performance in elite football players. The goal of this Funding…
2021-06-10 – Nature Research Awards for Inspiring Women in Science Application Deadline: Sunday, June 20, 2021 | 23:59 BST Nature Research Awards for Inspiring Women in Science are now open for applications. Awards are available in two categories: Science Outreach Category Scientific Achievement Category APPLY…
2021-06-09 – We spoke with ANA Past President David Holtzman, MD, the Andrew B. and Gretchen P. Jones Professor and Chairman of Neurology, Professor of Developmental Biology, Associate Director of the Alzheimer’s Disease Research Center, and scientific director of the Hope Center for Neurological Disorders. Dr…
2021-06-07 – Today, the U.S. Food and Drug Administration approved Aduhelm (aducanumab) for the treatment of Alzheimer’s, a debilitating disease affecting 6.2 million Americans. Aduhelm was approved using the accelerated approval pathway, which can be used for a drug for a serious or life-threatening illness…